Bellicum Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 264, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2023. Average receivable collection period, for the Bellicum Pharmaceuticals Inc in Sep 30 2023 quarter, has decreased to 1 days, compared to 60 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 6 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 65, from overall ranking in the second quarter 2023 at 3270.

What is Receivable Turnover Ratio?
What is Bellicum Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BLCM Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	-98.5 %	-	-96.14 %	-	79.86 %
Y / Y Revenue Change	-0.89 %	-76.92 %	-7.14 %	-1.57 %	-79.8 %
Receivable Turnover Ratio (TTM)	264	6.06	5.05	4.34	3.81
BLCM's Total Ranking	# 65	# 3270	# 3289	# 3475	# 2752
Accounts Receivable average collection period days	1	60	72	84	96
Seq. Receivable Change	-	-	-	-	378.47 %
Seq. Revenue Change	33300 %	-76.92 %	-97.4 %	-50.54 %	7676.92 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 2
Healthcare Sector	# 7
Overall Market	# 65

Receivable Turnover Ratio Statistics
High	Average	Low
257.39	18.18	0.55
(Sep 30 2023)		(Dec 31 2017)

BLCM Company Profile • Back to BLCM Efficiency Comparisons • Compare BLCM Receivables Turnover Ratio to its Competitors

Financial Statements
Bellicum Pharmaceuticals Inc 's Accounts Receivable	$ 0 Millions	Visit BLCM's Balance sheet
Bellicum Pharmaceuticals Inc 's Sales TTM	$ 2 Millions	Visit BLCM's Income Statement
Sources of BLCM's Revenues		Visit BLCM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BLCM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BLCM's Growth Rates	BLCM's Roa	BLCM's Inventory Turnover Ratio	BLCM's Dividend Comparisons
BLCM's Profitability Ratios	BLCM's Roi	BLCM's Asset Turnover Ratio	BLCM's Dividend Growth
BLCM's Valuation Ratios	BLCM's Roe	BLCM's Financial Strength Ratios	BLCM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
Pmgc Holdings Inc	264.69	$ 554.654 Millions	$ 2.096 Millions
Bellicum Pharmaceuticals Inc	264.00	$ 1.518 Millions	$ 0.006 Millions
Bausch Health Companies Inc	260.82	$ 8,542.000 Millions	$ 32.750 Millions
Carisma Therapeutics Inc	245.48	$ 50.630 Millions	$ 0.206 Millions
Waters Corporation	216.26	$ 2,995.452 Millions	$ 13.851 Millions
Earth Science Tech Inc	139.75	$ 2.196 Millions	$ 0.016 Millions
Nurix Therapeutics Inc	137.22	$ 68.611 Millions	$ 0.500 Millions
Point Biopharma Global Inc	128.59	$ 243.693 Millions	$ 1.895 Millions
Agape Atp Corporation	126.00	$ 1.427 Millions	$ 0.011 Millions
Healthlynked Corp	118.06	$ 5.946 Millions	$ 0.050 Millions
Relay Therapeutics Inc	117.14	$ 25.800 Millions	$ 0.220 Millions
Iterum Therapeutics Plc	115.26	$ 14.321 Millions	$ 0.124 Millions
Electromedical Technologies Inc	113.10	$ 1.420 Millions	$ 0.013 Millions
Prothena Corporation Public Limited Company	99.23	$ 140.977 Millions	$ 1.421 Millions
Orthofix Medical Inc	98.14	$ 667.747 Millions	$ 6.804 Millions
Logicmark Inc	80.11	$ 9.650 Millions	$ 0.120 Millions
Alpine Immune Sciences Inc	78.82	$ 30.799 Millions	$ 0.391 Millions
Renalytix Plc	77.82	$ 5.778 Millions	$ 0.074 Millions
Tango Therapeutics Inc	75.01	$ 37.507 Millions	$ 0.500 Millions
Kymera Therapeutics Inc	74.95	$ 46.846 Millions	$ 0.625 Millions
Longduoduo Co Ltd	69.41	$ 4.990 Millions	$ 0.072 Millions
Lifevantage Corp	67.38	$ 212.421 Millions	$ 3.153 Millions
Pavmed Inc	63.57	$ 1.923 Millions	$ 0.030 Millions
Scynexis Inc	62.10	$ 135.869 Millions	$ 2.188 Millions
Clearday Inc	61.82	$ 7.543 Millions	$ 0.122 Millions
Agenus Inc	61.81	$ 100.897 Millions	$ 1.632 Millions
Zeo Scientifix Inc	61.17	$ 4.558 Millions	$ 0.075 Millions
Lucid Diagnostics Inc	60.00	$ 1.500 Millions	$ 0.025 Millions
Airsculpt Technologies Inc	59.60	$ 189.013 Millions	$ 3.171 Millions
Brookdale Senior Living Inc	57.81	$ 2,949.838 Millions	$ 51.031 Millions

Date modified: 2026-08-29T17:21:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.